0,894  0,002  CTGF expression inhibitor
0,742  0,005  CYP2C19 substrate
0,722  0,005  NOS2 expression inhibitor
0,732  0,015  CYP3A4 substrate
0,718  0,008  CYP1A2 substrate
0,664  0,002  Neurotrophic factor enhancer
0,667  0,005  5 Hydroxytryptamine release inhibitor
0,661  0,009  UGT1A9 substrate
0,667  0,016  TNF expression inhibitor
0,656  0,005  Psychostimulant
0,656  0,007  Lipoxygenase inhibitor
0,647  0,007  Histamine release inhibitor
0,639  0,021  Teratogen
0,606  0,005  Diabetic retinopathy treatment
0,604  0,016  Antihypercholesterolemic
0,600  0,013  Spasmolytic
0,594  0,012  Antioxidant
0,597  0,019  Cholesterol antagonist
0,583  0,006  Antianorexic
0,606  0,052  Antiinflammatory
0,577  0,024  Embryotoxic
0,561  0,010  CYP1A2 inhibitor
0,580  0,034  Transcription factor NF kappa B inhibitor
0,569  0,025  CYP2C9 substrate
0,547  0,009  Antimutagenic
0,549  0,012  Free radical scavenger
0,533  0,005  Melanin inhibitor
0,530  0,006  Antiseptic
0,534  0,012  Antipyretic
0,528  0,017  Chemopreventive
0,507  0,003  Cannabinoid CB2 receptor antagonist
0,537  0,037  Alzheimer's disease treatment
0,504  0,012  UGT1A6 substrate
0,501  0,031  Atherosclerosis treatment
0,477  0,012  Sedative
0,482  0,023  AR expression inhibitor
0,465  0,006  Lipid peroxidase inhibitor
0,466  0,015  Antidiabetic symptomatic
0,463  0,015  Antihypertriglyceridemic
0,469  0,024  NOS3 expression inhibitor
0,503  0,073  Apoptosis agonist
0,450  0,021  Antiamyloidogenic
0,480  0,056  Antidiabetic
0,480  0,056  Cyclophilin D inhibitor
0,428  0,009  Thrombolytic
0,455  0,036  Ulceration
0,445  0,029  Lipoprotein disorders treatment
0,420  0,004  Estrogen receptor alpha antagonist
0,425  0,011  Non-steroidal antiinflammatory agent
0,458  0,046  Antipruritic, allergic
0,478  0,069  Caspase 9 stimulant
0,431  0,024  UGT2B4 substrate
0,411  0,004  SULT1A3 substrate
0,456  0,052  15-Lipoxygenase inhibitor
0,426  0,021  Amyloid beta aggregation inhibitor
0,426  0,023  Antiglaucomic
0,430  0,030  Chemoprotective
0,437  0,040  Bone diseases treatment
0,421  0,024  Hypoglycemic
0,396  0,004  TRPA1 agonist
0,390  0,003  SULT1A1 substrate
0,393  0,011  Genotoxic
0,374  0,013  Monophenol monooxygenase inhibitor
0,385  0,027  Nitric oxide antagonist
0,365  0,011  Protein kinase stimulant
0,431  0,079  Antiarthritic
0,382  0,032  Mutagenic
0,377  0,033  Cardiotonic
0,388  0,044  Antihypertensive
0,357  0,017  Antihypotensive
0,355  0,015  Skin whitener
0,370  0,031  Hypolipemic
0,404  0,066  GST A substrate
0,372  0,035  Carcinogenic
0,379  0,044  Radioprotector
0,397  0,064  Immunosuppressant
0,348  0,019  Contraceptive
0,348  0,023  UGT1A1 substrate
0,373  0,051  ICAM1 expression inhibitor
0,347  0,026  Abortion inducer
0,358  0,039  Antiprotozoal (Leishmania)
0,364  0,048  Cardioprotectant
0,339  0,029  5 Hydroxytryptamine uptake stimulant
0,308  0,010  Sulfotransferase substrate
0,328  0,032  Peroxidase inhibitor
0,319  0,028  RNA-directed DNA polymerase inhibitor
0,294  0,005  Coagulant
0,377  0,088  Antibacterial
0,292  0,005  Cannabinoid receptor antagonist
0,331  0,044  Proliferative diseases treatment
0,321  0,035  GST M1-1 substrate
0,356  0,071  Vasodilator, peripheral
0,328  0,048  Sensitization
0,297  0,018  UGT2B15 substrate
0,334  0,062  Antineoplastic (ovarian cancer)
0,298  0,026  VCAM1 expression inhibitor
0,282  0,014  Cholesterol synthesis inhibitor
0,277  0,012  Cystathionine beta-synthase inhibitor
0,329  0,065  12-Lipoxygenase inhibitor
0,329  0,066  Vasodilator, coronary
0,355  0,095  Antineoplastic (breast cancer)
0,314  0,054  Antineoplastic (glioma)
0,325  0,065  Respiratory analeptic
0,342  0,084  Antileukemic
0,275  0,017  Cyclooxygenase 1 inhibitor
0,294  0,036  UDP-glucuronosyltransferase substrate
0,279  0,023  Hair growth stimulant
0,340  0,087  CYP2C9 inhibitor
0,300  0,048  Vasodilator
0,260  0,010  UGT2B1 substrate
0,255  0,005  Electron transport complex I inhibitor
0,314  0,067  Sodium/bile acid cotransporter inhibitor
0,325  0,078  Antiallergic
0,316  0,069  Antipsoriatic
0,297  0,052  Cytotoxic
0,340  0,097  CYP2C19 inhibitor
0,320  0,077  Antithrombotic
0,257  0,015  5-Lipoxygenase inhibitor
0,289  0,047  Antineoplastic (sarcoma)
0,312  0,070  Antiischemic
0,278  0,037  Growth hormone agonist
0,245  0,004  Cannabinoid CB1 receptor antagonist
0,257  0,016  Antifungal enhancer
0,265  0,027  UGT1A3 substrate
0,269  0,032  Pneumotoxic
0,311  0,075  Antifungal
0,272  0,037  Muscle relaxant
0,271  0,036  UGT1A4 substrate
0,258  0,025  Cyclooxygenase inhibitor
0,265  0,036  UGT2B7 substrate
0,281  0,053  Antineoplastic (glioblastoma multiforme)
0,301  0,074  Analeptic
0,256  0,033  Antipruritic, non-allergic
0,226  0,006  Posttraumatic stress disorder treatment
0,247  0,027  Prostate disorders treatment
0,238  0,019  DNA polymerase I inhibitor
0,223  0,006  Prolactin inhibitor
0,227  0,010  Estrogen antagonist
0,334  0,117  Antiparkinsonian
0,290  0,074  Antineoplastic (melanoma)
0,236  0,020  Glutathione S-transferase substrate
0,284  0,070  Antidiabetic (type 2)
0,236  0,023  Cyclooxygenase 2 inhibitor
0,284  0,075  5 Hydroxytryptamine release stimulant
0,246  0,039  CYP2B6 inhibitor
0,220  0,015  Bronchodilator
0,241  0,040  Insulin sensitizer
0,292  0,092  FMO1 substrate
0,237  0,040  Eye irritation, high
0,205  0,011  Vanilloid 1 agonist
0,204  0,009  Estrogen receptor beta antagonist
0,273  0,079  Antiosteoporotic
0,286  0,092  Prostate cancer treatment
0,213  0,019  Interleukin 4 antagonist
0,236  0,045  Antianginal
0,214  0,024  Antihyperlipoproteinemic
0,262  0,072  Antineoplastic (renal cancer)
0,236  0,048  Hepatoprotectant
0,211  0,023  Neurotrophic factor
0,197  0,015  Adenylate cyclase stimulant
0,202  0,021  Antihemorrhagic
0,229  0,049  P-glycoprotein inhibitor
0,279  0,101  Apoptosis antagonist
0,183  0,006  TRPA1 antagonist
0,180  0,004  SULT1A2 substrate
0,245  0,069  Cytostatic
0,187  0,012  Actinic keratosis treatment
0,235  0,060  Antiarrhythmic
0,246  0,072  Tyrosine 3 hydroxylase inhibitor
0,254  0,081  Amyotrophic lateral sclerosis treatment
0,196  0,023  Farnesoid X receptor antagonist
0,242  0,071  Cardiodepressant
0,182  0,012  NAD(P)H dehydrogenase (quinone) inhibitor
0,188  0,019  Alcohol dehydrogenase substrate
0,173  0,007  Ornithine decarboxylase inhibitor
0,257  0,093  Immunostimulant
0,166  0,003  Vanilloid 2 antagonist
0,207  0,044  Protein-tyrosine phosphatase inhibitor
0,172  0,009  Anabolic
0,241  0,078  Cardiovascular analeptic
0,183  0,021  Sphingosine 1-phosphate receptor 5 antagonist
0,179  0,018  Photosensitizer
0,258  0,097  CYP2D6 inhibitor
0,201  0,042  Phospholipase A2 inhibitor
0,187  0,030  Proteasome inhibitor
0,186  0,031  CF transmembrane conductance regulator agonist
0,173  0,019  Sphingosine 1-phosphate receptor 2 antagonist
0,252  0,099  FMO3 substrate
0,249  0,097  Antineoplastic (multiple myeloma)
0,163  0,012  Aromatase inhibitor
0,170  0,019  Sphingosine 1-phosphate receptor 4 antagonist
0,176  0,026  Xanthine oxidase inhibitor
0,168  0,021  Papain-like protease (SARS coronavirus) inhibitor
0,212  0,066  Wound healing agent
0,265  0,120  Antineoplastic (small cell lung cancer)
0,172  0,028  Endometrios treatment
0,194  0,050  Acaricide
0,161  0,020  Androgen antagonist
0,251  0,111  Caspase 3 stimulant
0,186  0,047  NOS3 expression enhancer
0,186  0,047  Interferon gamma antagonist
0,157  0,018  DOPA decarboxylase inhibitor
0,185  0,048  Arachidonic acid antagonist
0,149  0,011  Antifungal (Candida)
0,186  0,049  UGT2B10 substrate
0,242  0,108  Hypoxia-inducible factor 1 alpha inhibitor
0,144  0,012  Estrogen agonist
0,172  0,041  Skin irritative effect
0,195  0,065  Myocardial ischemia treatment
0,155  0,026  Aldehyde dehydrogenase substrate
0,167  0,039  Protein-tyrosine phosphatase 1B inhibitor
0,248  0,120  Interleukin 2 agonist
0,240  0,113  Metabolic disease treatment
0,201  0,074  Anesthetic general
0,239  0,112  CYP2D6 substrate
0,184  0,057  Phospholipase C inhibitor
0,183  0,057  Muscular dystrophy treatment
0,175  0,050  Antiacne
0,162  0,040  Retinoprotector
0,173  0,051  Skeletal muscle relaxant
0,195  0,076  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,141  0,024  Alcohol dehydrogenase inhibitor
0,172  0,057  UGT2B9 substrate
0,164  0,049  Bone formation stimulant
0,126  0,016  Vanilloid agonist
0,124  0,014  Leukotriene antagonist
0,123  0,014  Cannabinoid CB1 receptor agonist
0,203  0,093  Angiogenesis stimulant
0,113  0,004  Retinoid X receptor agonist
0,185  0,076  Antihelmintic
0,208  0,100  Aldehyde oxidase inhibitor
0,186  0,080  VEGF expression inhibitor
0,156  0,052  Psychosexual dysfunction treatment
0,123  0,019  Peroxisome proliferator-activated receptor gamma agonist
0,148  0,049  Ca2+-transporting ATPase inhibitor
0,143  0,044  Gastritis treatment
0,207  0,110  DNA damaging
0,110  0,013  Maillard reaction inhibitor
0,191  0,094  Antiparasitic
0,167  0,074  Prostatic (benign) hyperplasia treatment
0,172  0,080  Antirickettsial
0,138  0,045  Contraceptive female
0,173  0,082  LDLR expression enhancer
0,147  0,056  Carcinogenic, group 3
0,101  0,011  Estrogen receptor beta agonist
0,240  0,151  Stroke treatment
0,220  0,134  Hepatic disorders treatment
0,113  0,028  Bile acid receptor antagonist
0,096  0,012  Enoyl-[acyl-carrier-protein] reductase inhibitor
0,152  0,067  Movement disorders treatment
0,100  0,017  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,183  0,101  Antiulcerative
0,106  0,023  Leukotriene synthesis inhibitor
0,243  0,161  GABA C receptor rho-3 antagonist
0,224  0,142  Antineoplastic (lung cancer)
0,157  0,077  Uterine stimulant
0,092  0,012  Leukotriene B4 antagonist
0,103  0,025  Lipase inhibitor
0,122  0,045  Carbonic anhydrase XV inhibitor
0,156  0,080  Interleukin 6 antagonist
0,164  0,088  Succinate dehydrogenase inhibitor
0,181  0,106  Antineoplastic enhancer
0,118  0,045  Carbonic anhydrase III inhibitor
0,087  0,015  Peroxisome proliferator-activated receptor alpha agonist
0,106  0,035  Carbonic anhydrase XIII inhibitor
0,075  0,004  ATP citrate lysase inhibitor
0,109  0,040  ABCA1 expression enhancer
0,141  0,072  Heat shock protein 70 antagonist
0,111  0,043  UGT2B11 substrate
0,133  0,065  Toll-Like receptor 2 antagonist
0,079  0,012  Estrogen receptor alpha agonist
0,098  0,031  Keratolytic
0,128  0,061  Alkylator
0,185  0,118  Antineoplastic (non-small cell lung cancer)
0,089  0,023  Peroxisome proliferator-activated receptor gamma antagonist
0,095  0,030  CDC25A inhibitor
0,109  0,045  Uric acid excretion stimulant
0,093  0,031  Prostaglandin-E synthase inhibitor
0,090  0,030  HIV-1 integrase (3'-Processing) inhibitor
0,079  0,019  Fatty acid synthase inhibitor
0,177  0,118  Antineoplastic (cervical cancer)
0,154  0,095  ATPase inhibitor
0,103  0,045  Antineoplastic antibiotic
0,093  0,035  Interferon agonist
0,192  0,135  DNA synthesis inhibitor
0,102  0,046  SULT1E1 substrate
0,149  0,095  Dual specificity phosphatase inhibitor
0,113  0,059  Choleretic
0,192  0,139  Antineurogenic pain
0,136  0,084  Antifungal (Cryptococcus)
0,078  0,026  Glutamate (mGluR6) antagonist
0,056  0,004  Thiazolidinedione
0,067  0,016  Mineralocorticoid receptor antagonist
0,158  0,108  Sepsis treatment
0,071  0,021  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,110  0,060  Carcinogenic, group 2B
0,100  0,052  Phosphodiesterase 6D inhibitor
0,059  0,012  Glucocorticoid antagonist
0,191  0,145  Flavin-containing monooxygenase substrate
0,204  0,158  Thyroid hormone antagonist
0,136  0,090  Antidiarrheal
0,182  0,137  Interleukin agonist
0,076  0,033  HIV-1 integrase (Strand Transfer) inhibitor
0,046  0,003  Vanilloid 2 agonist
0,076  0,035  Endocannabinoid uptake inhibitor
0,066  0,026  Alpha tubulin antagonist
0,139  0,099  Antihelmintic (Nematodes)
0,105  0,066  Topoisomerase I inhibitor
0,166  0,127  Cyclic AMP phosphodiesterase inhibitor
0,062  0,024  Leukotriene C antagonist
0,065  0,030  Sphingosine kinase inhibitor
0,113  0,078  Aldehyde dehydrogenase inhibitor
0,182  0,148  Antineoplastic (colorectal cancer)
0,065  0,031  Beta 2 adrenoreceptor agonist
0,038  0,007  Thyroid hormone agonist
0,067  0,036  Transcription factor RelA inhibitor
0,041  0,011  Leukotriene B4 receptor 1 antagonist
0,047  0,018  TRPM8 blocker
0,108  0,079  Topoisomerase II inhibitor
0,048  0,019  Progesterone antagonist
0,054  0,026  Potassium channel Kv1.3 blocker
0,136  0,109  Dual specificity phosphatase 3 inhibitor
0,039  0,012  Calcium-independent phospholipase A2 inhibitor
0,115  0,089  Nav1.2 sodium channel blocker
0,170  0,145  Antineoplastic (colon cancer)
0,066  0,041  Interferon inducer
0,182  0,158  Antiviral (West Nile virus)
0,108  0,084  Growth stimulant
0,058  0,035  Acetyl-CoA transferase 2 inhibitor
0,140  0,118  Platelet adhesion inhibitor
0,033  0,011  Sodium/glucose cotransporter 2 inhibitor
0,031  0,010  Toll-Like receptor 4 agonist
0,186  0,167  Thyroid hormone beta antagonist
0,086  0,068  Paget's disease treatment
0,082  0,063  Antineoplastic alkaloid
0,041  0,022  Leukotriene C4 antagonist
0,030  0,011  Sodium/glucose cotransporter inhibitor
0,164  0,146  Myocardial infarction treatment
0,024  0,006  Thyroid hormone alpha antagonist
0,049  0,031  Cholesterol esterase inhibitor
0,079  0,062  Glutathione S-transferase inhibitor
0,169  0,152  Antiprotozoal (Trypanosoma)
0,061  0,045  Antimycoplasmal
0,120  0,106  Antidote
0,037  0,022  Retinoid X alpha receptor agonist
0,107  0,094  Tubulin antagonist
0,043  0,030  Liver X receptor agonist
0,052  0,039  Acetyl-CoA transferase inhibitor
0,071  0,059  Na+ K+ transporting ATPase inhibitor
0,122  0,111  Heat shock protein 90 antagonist
0,076  0,064  Glycine receptor antagonist
0,066  0,055  Andropause treatment
0,024  0,013  Leukotriene B4 receptor 2 antagonist
0,026  0,016  Sodium/glucose cotransporter 1 inhibitor
0,063  0,053  Cyclin B3 inhibitor
0,023  0,014  Peroxisome proliferator-activated receptor alpha antagonist
0,038  0,029  Retinoic acid alpha receptor agonist
0,024  0,015  Retinoic acid receptor agonist
0,167  0,159  Superoxide dismutase inhibitor
0,078  0,069  Antiviral (Trachoma)
0,039  0,031  Liver X receptor alpha agonist
0,086  0,078  Creatine kinase inhibitor
0,040  0,032  Sphingosine kinase 1 inhibitor
0,136  0,130  Hearing loss treatment
0,018  0,012  Progesterone agonist
0,086  0,080  Dementia treatment
0,084  0,078  Vascular dementia treatment
0,036  0,030  Retinoid X receptor antagonist
0,117  0,112  Antiviral (Influenza A)
0,051  0,046  Sphingosine 1-phosphate receptor 5 agonist
0,159  0,154  Antineoplastic (liver cancer)
0,087  0,082  Urease inhibitor
0,058  0,054  CDC25B inhibitor
0,077  0,074  GST P1-1 substrate
0,054  0,050  Androgen agonist
0,056  0,052  Ryanodine receptor antagonist
0,021  0,018  Prostaglandin F2 alpha agonist
0,033  0,030  5-Alpha-reductase inhibitor
0,021  0,019  Dopamine D1 agonist
0,031  0,028  Peroxisome proliferator-activated receptor delta antagonist
0,015  0,013  Thyroid hormone alpha agonist
0,081  0,079  Thioredoxin inhibitor
0,063  0,062  Anticholelithogenic
0,089  0,088  AMP-activated protein kinase stimulant
0,172  0,171  Radiosensitizer
0,087  0,086  Gout treatment

